Consistent with previously-reported transcriptomic analyses of tumours following treatment with IgE in vivo [23], we found heightened classical immune activation signalling pathways (e.g., FcγR signalling and functions, and CD28 co-stimulation signalling) following IgE cross-linking (Figure 3D). This evidence concerns the gene CD28 and neoplasm.